Library
Бромонордиазепам
Bromonordiazepam (also called desalkylgidazepam) is the active metabolite of the Ukrainian anxiolytic gidazepam and is now sold online as a long-acting research chemical benzodiazepine. Recreational users estimate approximately 6 mg equals 10 mg diazepam, placing it at roughly 0.6× diazepam potency. Light anxiolysis emerges at 3-6 mg, while sleep-inducing doses of 15 mg and above risk prolonged psychomotor impairment the next day. The elimination half-life averages 86-90 hours, with forensic casework suggesting a range of 72-120 hours; metabolites can be detected in urine up to 18 days post-dose. Because of this exceptionally long half-life, every-other-day dosing is recommended to avoid accumulation.
Also known as: Bromo-nordazepam, Desalkylgidazepam
Classification
- Chemical: Benzodiazepine
- Psychoactive: Depressant
- Tag: Anticonvulsant
- Tag: Anxiolytic
- Tag: Muscle Relaxant
- Tag: Research-Chemical
- Tag: Sedative
Effects
- Muscle Relaxation
- Sedation
- Physical Euphoria
- Motor Impairment
- Incoordination
- Impaired Balance
- Anxiety Suppression
- Memory Suppression
- Motor Control Loss
- Thought Deceleration
- Reduced Anxiety
- Euphoria
- Disinhibition
- Dulled Perception
- Open Eye Visuals
- Double Vision
- Blurred Vision
- Visual Acuity Suppression
Routes of Administration
Oral
Dosage
- Threshold: 2 mg
- Light: 3-6 mg
- Common: 6-15 mg
- Strong: 15-25 mg
- Heavy: 25 mg
Duration
- Onset: 0.33-1 h
- Comeup: 0.5-1.5 h
- Peak: 2-4 h
- Offset: 3-6 h
- After Effects: 12-48 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
